ExploreConditionPremature baby oral feeding plate
Condition

Premature baby oral feeding plate

Also known as: Premature baby oral feeding plate Premature baby oral feeding plate (physical object) oral feeding failure in prematurity; bronchopulmonary dysplasia; severe intraventricular hemorrhage; periventricular leukomalacia; small for gestational age oral feeding failure in prematurity; necrotizing enterocolitis; short bowel syndrome oral feeding failure in prematurity; neurodevelopmental impairment; cerebral palsy; cognitive impairment; language delays; chronic breathing problems; chronic feeding problems oral feeding failure in prematurity; neurodevelopmental impairment; chronic breathing problems oral feeding failure; chronic breathing problems; chronic feeding problems; neurodevelopmental impairment; cerebral palsy GA
15 findings 1 paper 7 related entities View in graph →

Related entities

interventions
outcomes
populations
studys

Findings (50)

None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10

Papers (1)